Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial
| Image |  |
|---|---|
| Description | scholarly article published in March 2024 |
| Author/s |
author: Byoung Gie Kim |
| Publication date | March 2024 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |